HOME >> BIOLOGY >> NEWS
High Density Lipoproteins And Coronary Heart Disease

Renowned scientists in the field of lipid research will lead a symposium entitled High Density Lipoproteins and Coronary Heart Disease on Saturday, November 7, 1998 in Dallas, TX. Scientists will review the hypothesis that low levels of high-density lipoprotein (HDL) cholesterol are a risk for coronary heart disease; discuss metabolic disorders that result in this condition; and evaluate treatment options.

The symposium, accredited by Continuing Medical Education at The Johns Hopkins University School of Medicine, will include presentations by:

  • Ernst Schaefer, MD, chief, Lipid Metabolism Laboratory, USDA Human Nutrition Research Center at Tufts University
  • H. Bryan Brewer, MD, chief, Molecular Diseases Branch, National Heart, Lung, and Blood Institute, National Institutes of Health
  • Moti Kashyup, MD, director, Cholesterol Center, Veterans Affairs Medical Center
  • John Guyton, MD, director, Duke Lipid Clinic, Duke University Medical Center
  • Hanna Rubins, MD, associate professor of medicine, University of Minnesota School of Medicine. Dr. Rubins, the Lead Investigator for the High-Density Lipoprotein Intervention Trials (HIT), will be presenting data from HIT on Wednesday, November 11 at 1:00 pm during the American Heart Association Conference.


'"/>

Contact: Karen Peart
k.peart@noonanrusso.com
212-696-4455 ext.343
Noonan/Russo Communications
15-Oct-1998


Page: 1

Related biology news :

1. Study Ensures Effective Ways To Measure Macular Pigment Density
2. Reanalysis Of International Data Finds Sharp Decline In Sperm Density
3. Depression A Risk Factor For Coronary Artery Disease In Men
4. American Heart Association Comment: "Folate And Vitamin B6 From Diet And Supplements In Relation To Risk Of Coronary Heart Disease Among Women"
5. Heart gene yields insights into evolution, disease risk
6. Heartless worms hold clues to cardiac arrhythmias, sudden death
7. Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24
8. Heart and lung transplantation clinical trial results to be announced at ISHLT meeting
9. Heart may heal with help from oxygen-sensitive genes, new study suggests
10. Heart drug might help fight chronic fungal infections
11. Heart disease among some Japanese may be due to sequencing variation inside a gene

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2020)... ... August 21, 2020 , ... The August ... published and is now available on the company’s global website. Crystallography Times—an electronic ... community, presenting current news and crystallographic research. , The latest issue of ...
(Date:8/12/2020)... ... 2020 , ... Both Roche, based in Basel, Switzerland, and ... with Housey Pharma’s HMI subsidiary to gain access to its core-enabling technology for ... Development spending in excess of US $10 billion. , Scientists at Housey Pharma ...
(Date:8/3/2020)... ... August 03, 2020 , ... Accumen Inc. is ... medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. ... chain for more than 10 years. Early in the COVID-19 crisis, we identified ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Slone Partners , ... announced the placement of Julianne Averill , CPA, as Chief Financial Officer ... operations and implementing key business strategies to accelerate Alveo’s growth as the company ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... making available for free its new white paper – Simulated Transport Methodologies. ... into today’s biologics licensing application (BLA). In response, Modality Solutions shares an ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering patients ... million stem cells total, patients may choose which extremities they would like treated. , ... (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as the solution ... history of eSource, the reasons it did not take off as quickly as people ... the industry is moving towards capturing data electronically for clinical trials and then repurposing ...
Breaking Biology Technology:
Cached News: